orthopedics. Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate
Conditions
Interventions
Intervention 1: Intervention group: Participants in the intervention group received 0.2 mg of oral tizanidine as a single dose. The drug was administered orally as a coated tablet with approximately 5
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Anesthesia class (ASA I and ASA II) Consent to participate in the study
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding for women History of underlying cardiopulmonary diseases History of kidney disease High blood pressure Thrombocytopenia Asthma The patient's urgent need for a blood transfusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic signs (systolic and diastolic blood pressure, heart rate, arterial blood oxygen saturation). Timepoint: Before taking the medication, half an hour later, before induction, 15, 30, 45, and 60 minutes after induction, and upon entering and leaving recovery. Method of measurement: Monitoring.;Muscle weakness. Timepoint: At times 15, 30, 45, 60, 90, 120 and 180 during the operation. Method of measurement: Intraoperative questioning of the surgeon's satisfaction with muscle laxity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNavid Kalani
Jahrom University of Medical Sciences
Outcome results
None listed